Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konrad Lewandowski

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Polish Archives of Internal Medicine|December 14, 2020
Clostridioides difficile infection in coronavirus disease 2019 (COVID-19): an underestimated problem?Konrad Lewandowski, Mariusz Rosołowski, Magdalena Kaniewska, et al.
Scientific Reports|February 20, 2026
Development of a UPLC-MS/MS method and its application for the pharmacokinetic analysis of regorafenib in ratsFilip Otto, Viktoriia Propisnova, Hanna Urjasz, et al.
Journal of Personalized Medicine|March 29, 2023
Effect of Intravenous Iron Administration on Bone Mineral and Iron Homeostasis in Patients with Inflammatory Bowel Disease-Results of a Prospective Single-Centre StudyEdyta Tulewicz-Marti, Paulina Szwarc, Martyna Więcek, et al.
Journal of Personalized Medicine|June 28, 2023
Awareness and Compliance with the Recommendations of Primary and Secondary Prevention of Cancer in Patients with Inflammatory Bowel DiseaseEdyta Tulewicz-Marti, Beata Stępień-Wrochna, Katarzyna Maciejewska, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 28, 2026
Drug-related problems in hospitalized oncology patients, with special focus on radiotherapy units: Implications for oncology pharmacy practiceKatarzyna Regulska, Marcin Michalak, Beata Janiszewska, et al.
Chemosphere|July 21, 2020
Precursors of polychlorinated dibenzo-p-dioxins and dibenzofurans in Arctic and Antarctic marine sediments: Environmental concern in the face of climate changeMarta Ewelina Kobusińska, Krzysztof Konrad Lewandowski, Anna Panasiuk, et al.
Journal of Clinical Medicine|September 14, 2024
Should the Dermatological Assessment of Patients with Inflammatory Bowel Disease Become Standard during Qualifications for Biological Treatment? A Retrospective, Single-Center Experience from a Tertiary CenterKonrad Lewandowski, Magdalena Kaniewska, Edyta Tulewicz-Marti, et al.
Nutrients|March 11, 2023
Risk Factors for Osteoporosis among Patients with Inflammatory Bowel Disease-Do We Already Know Everything?Konrad Lewandowski, Magdalena Kaniewska, Martyna Więcek, et al.
Przeglad Gastroenterologiczny|August 4, 2023
Long-lasting dyspeptic symptoms - another consequence of the COVID-19 pandemic?Anna Nazarewska, Konrad Lewandowski, Magdalena Kaniewska, et al.
Przeglad Gastroenterologiczny|December 31, 2025
Fecal butyric acid as a predictive biomarker of endoscopic remission in inflammatory bowel disease: a multicenter prospective studyKatarzyna Karłowicz, Konrad Lewandowski, Danuta Domżał-Magrowska, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Polish Archives of Internal Medicine|December 14, 2020
Clostridioides difficile infection in coronavirus disease 2019 (COVID-19): an underestimated problem?Konrad Lewandowski, Mariusz Rosołowski, Magdalena Kaniewska, et al.
Scientific Reports|February 20, 2026
Development of a UPLC-MS/MS method and its application for the pharmacokinetic analysis of regorafenib in ratsFilip Otto, Viktoriia Propisnova, Hanna Urjasz, et al.
Journal of Personalized Medicine|March 29, 2023
Effect of Intravenous Iron Administration on Bone Mineral and Iron Homeostasis in Patients with Inflammatory Bowel Disease-Results of a Prospective Single-Centre StudyEdyta Tulewicz-Marti, Paulina Szwarc, Martyna Więcek, et al.
Journal of Personalized Medicine|June 28, 2023
Awareness and Compliance with the Recommendations of Primary and Secondary Prevention of Cancer in Patients with Inflammatory Bowel DiseaseEdyta Tulewicz-Marti, Beata Stępień-Wrochna, Katarzyna Maciejewska, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 28, 2026
Drug-related problems in hospitalized oncology patients, with special focus on radiotherapy units: Implications for oncology pharmacy practiceKatarzyna Regulska, Marcin Michalak, Beata Janiszewska, et al.
Chemosphere|July 21, 2020
Precursors of polychlorinated dibenzo-p-dioxins and dibenzofurans in Arctic and Antarctic marine sediments: Environmental concern in the face of climate changeMarta Ewelina Kobusińska, Krzysztof Konrad Lewandowski, Anna Panasiuk, et al.
Journal of Clinical Medicine|September 14, 2024
Should the Dermatological Assessment of Patients with Inflammatory Bowel Disease Become Standard during Qualifications for Biological Treatment? A Retrospective, Single-Center Experience from a Tertiary CenterKonrad Lewandowski, Magdalena Kaniewska, Edyta Tulewicz-Marti, et al.
Nutrients|March 11, 2023
Risk Factors for Osteoporosis among Patients with Inflammatory Bowel Disease-Do We Already Know Everything?Konrad Lewandowski, Magdalena Kaniewska, Martyna Więcek, et al.
Przeglad Gastroenterologiczny|August 4, 2023
Long-lasting dyspeptic symptoms - another consequence of the COVID-19 pandemic?Anna Nazarewska, Konrad Lewandowski, Magdalena Kaniewska, et al.
Przeglad Gastroenterologiczny|December 31, 2025
Fecal butyric acid as a predictive biomarker of endoscopic remission in inflammatory bowel disease: a multicenter prospective studyKatarzyna Karłowicz, Konrad Lewandowski, Danuta Domżał-Magrowska, et al.
Pageof 4